Clinical Trials on Prostate Cancer Metastatic Disease in Sweden
Total 890 results
-
DexTech Medical ABTerminatedProstate Cancer MetastaticSweden
-
Astellas Pharma a/sCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Jeffrey Yachnin M.D., PhD.SanofiCompletedMetastatic Castration Resistant Prostate CancerSweden
-
DexTech Medical ABCompletedProstate Cancer MetastaticSweden
-
DexTech Medical ABUnknownProstate Cancer MetastaticEstonia, Sweden, Finland, Latvia
-
BayerCompletedMetastatic Castration-Resistant Prostate CancerSweden
-
Tavanta TherapeuticsCompletedMetastatic Prostate Cancer | Metastatic Castration-sensitive Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Hungary, France, Poland, Puerto Rico, Sweden
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Umeå UniversityKarolinska University Hospital; Vastra Gotaland Region; Region Jönköping County; Region Skane and other collaboratorsRecruitingProstate Cancer Metastatic | Positron-Emission Tomography | Radiation TherapySweden
-
Lund University HospitalCompleted
-
Umeå UniversityRecruitingProstate Cancer | Metastatic Cancer | Radiotherapy Side EffectSweden
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
Lund UniversitySwedish Cancer Foundation; ALF Swedish Government GrantCompletedProstate Cancer RecurrentSweden
-
SanofiGenzyme, a Sanofi CompanyCompletedProstate Cancer | Metastatic | Hormone RefractoryBrazil, South Africa, Sweden, Germany, Hungary
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
BayerCompletedNeoplasm Metastasis | Prostate CancerSweden, United Kingdom
-
Sahlgrenska University Hospital, SwedenGöteborg UniversityRecruiting
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Orion Corporation, Orion PharmaCompleted
-
Örebro University, SwedenUnknown
-
Karolinska University HospitalPhilips Electronics Nederland B.V. acting through Philips CTO organizationCompleted
-
Karolinska InstitutetRegion StockholmCompleted
-
Uppsala UniversityKarolinska Institutet; Cyto Pulse Sciences, Inc.Completed
-
University Hospital, LinkoepingSahlgrenska University Hospital, Sweden; Medical Research Council of Southeast...RecruitingColorectal Cancer Metastatic | Chemotherapy Effect | Tumour Metastasis | Tumor GrowthSweden
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
Karolinska InstitutetCompleted
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Karolinska InstitutetKarolinska University HospitalRecruiting
-
Kronoberg County CouncilCompleted
-
Region SkaneRecruitingProstate Cancer (Diagnosis)Sweden
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Region SkaneCompleted
-
Lidds ABUppsala UniversityCompletedProstate CancerFinland, Sweden
-
Karolinska InstitutetCompleted
-
Astellas Pharma Europe Ltd.Completed
-
Karolinska InstitutetKarolinska University HospitalCompleted
-
Örebro University, SwedenCompleted
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
Region SkaneEnrolling by invitationCancer of Lung | Cancer of Prostate | Lung MetastasisSweden
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Poland, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Janssen Research & Development, LLCCompletedMetastatic Prostate CancerUnited States, Korea, Republic of, Australia, Poland, Taiwan, France, Thailand, Malaysia, Russian Federation, Canada, Bulgaria, Italy, Spain, Turkey, Sweden, Israel, Belarus, Ukraine, Brazil, Argentina, Belgium, Denmark, United Kingdom and more
-
Astellas Pharma Europe Ltd.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration Resistant Prostate CancerBelgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
-
Karolinska InstitutetActive, not recruitingProstate CancerSweden
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
Elin TragardhLund UniversityRecruiting